Medical Devices & Consumables
Global Juvenile Idiopathic Arthritis Diagnostic Market Research Report 2026
- Feb 24, 26
- ID: 717977
- Pages: 120
- Figures: 115
- Views: 1
This report delivers a comprehensive overview of the global Juvenile Idiopathic Arthritis Diagnostic market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Juvenile Idiopathic Arthritis Diagnostic. The Juvenile Idiopathic Arthritis Diagnostic market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Juvenile Idiopathic Arthritis Diagnostic market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Juvenile Idiopathic Arthritis Diagnostic manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Siemens
Philips
GE
Canon Medical
Hitachi
United Imaging
Segment by Type
Blood Tests
Imaging Scans
Segment by Application
Hospitals
Laboratories
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Juvenile Idiopathic Arthritis Diagnostic companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Juvenile Idiopathic Arthritis Diagnostic market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Juvenile Idiopathic Arthritis Diagnostic manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Siemens
Philips
GE
Canon Medical
Hitachi
United Imaging
Segment by Type
Blood Tests
Imaging Scans
Segment by Application
Hospitals
Laboratories
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Juvenile Idiopathic Arthritis Diagnostic companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Blood Tests
1.2.3 Imaging Scans
1.3 Market by Application
1.3.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Perspective (2021–2032)
2.2 Global Juvenile Idiopathic Arthritis Diagnostic Growth Trends by Region
2.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Region (2021–2026)
2.2.3 Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Region (2027–2032)
2.3 Juvenile Idiopathic Arthritis Diagnostic Market Dynamics
2.3.1 Juvenile Idiopathic Arthritis Diagnostic Industry Trends
2.3.2 Juvenile Idiopathic Arthritis Diagnostic Market Drivers
2.3.3 Juvenile Idiopathic Arthritis Diagnostic Market Challenges
2.3.4 Juvenile Idiopathic Arthritis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Revenue
3.1.1 Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Revenue (2021–2026)
3.1.2 Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Players (2021–2026)
3.2 Global Top Juvenile Idiopathic Arthritis Diagnostic Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Juvenile Idiopathic Arthritis Diagnostic Revenue
3.4 Global Juvenile Idiopathic Arthritis Diagnostic Market Concentration Ratio
3.4.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Juvenile Idiopathic Arthritis Diagnostic Revenue in 2025
3.5 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic Head Offices and Areas Served
3.6 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Products and Applications
3.7 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Juvenile Idiopathic Arthritis Diagnostic Breakdown Data by Type
4.1 Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Type (2021–2026)
4.2 Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Type (2027–2032)
5 Juvenile Idiopathic Arthritis Diagnostic Breakdown Data by Application
5.1 Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Application (2021–2026)
5.2 Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
6.2 North America Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)
6.4 North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
7.2 Europe Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)
7.4 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
8.2 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2021–2026)
8.4 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
9.2 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)
9.4 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
10.2 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)
10.4 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Juvenile Idiopathic Arthritis Diagnostic Introduction
11.1.4 Roche Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Juvenile Idiopathic Arthritis Diagnostic Introduction
11.2.4 Abbott Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.2.5 Abbott Recent Development
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher Juvenile Idiopathic Arthritis Diagnostic Introduction
11.3.4 Danaher Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.3.5 Danaher Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Introduction
11.4.4 Siemens Healthineers Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.4.5 Siemens Healthineers Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Sysmex
11.6.1 Sysmex Company Details
11.6.2 Sysmex Business Overview
11.6.3 Sysmex Juvenile Idiopathic Arthritis Diagnostic Introduction
11.6.4 Sysmex Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.6.5 Sysmex Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Juvenile Idiopathic Arthritis Diagnostic Introduction
11.7.4 BioMerieux Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.7.5 BioMerieux Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Juvenile Idiopathic Arthritis Diagnostic Introduction
11.8.4 Siemens Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.8.5 Siemens Recent Development
11.9 Philips
11.9.1 Philips Company Details
11.9.2 Philips Business Overview
11.9.3 Philips Juvenile Idiopathic Arthritis Diagnostic Introduction
11.9.4 Philips Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.9.5 Philips Recent Development
11.10 GE
11.10.1 GE Company Details
11.10.2 GE Business Overview
11.10.3 GE Juvenile Idiopathic Arthritis Diagnostic Introduction
11.10.4 GE Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.10.5 GE Recent Development
11.11 Canon Medical
11.11.1 Canon Medical Company Details
11.11.2 Canon Medical Business Overview
11.11.3 Canon Medical Juvenile Idiopathic Arthritis Diagnostic Introduction
11.11.4 Canon Medical Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.11.5 Canon Medical Recent Development
11.12 Hitachi
11.12.1 Hitachi Company Details
11.12.2 Hitachi Business Overview
11.12.3 Hitachi Juvenile Idiopathic Arthritis Diagnostic Introduction
11.12.4 Hitachi Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.12.5 Hitachi Recent Development
11.13 United Imaging
11.13.1 United Imaging Company Details
11.13.2 United Imaging Business Overview
11.13.3 United Imaging Juvenile Idiopathic Arthritis Diagnostic Introduction
11.13.4 United Imaging Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.13.5 United Imaging Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Blood Tests
1.2.3 Imaging Scans
1.3 Market by Application
1.3.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Perspective (2021–2032)
2.2 Global Juvenile Idiopathic Arthritis Diagnostic Growth Trends by Region
2.2.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Region (2021–2026)
2.2.3 Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Region (2027–2032)
2.3 Juvenile Idiopathic Arthritis Diagnostic Market Dynamics
2.3.1 Juvenile Idiopathic Arthritis Diagnostic Industry Trends
2.3.2 Juvenile Idiopathic Arthritis Diagnostic Market Drivers
2.3.3 Juvenile Idiopathic Arthritis Diagnostic Market Challenges
2.3.4 Juvenile Idiopathic Arthritis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Revenue
3.1.1 Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Revenue (2021–2026)
3.1.2 Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Players (2021–2026)
3.2 Global Top Juvenile Idiopathic Arthritis Diagnostic Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Juvenile Idiopathic Arthritis Diagnostic Revenue
3.4 Global Juvenile Idiopathic Arthritis Diagnostic Market Concentration Ratio
3.4.1 Global Juvenile Idiopathic Arthritis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Juvenile Idiopathic Arthritis Diagnostic Revenue in 2025
3.5 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic Head Offices and Areas Served
3.6 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Products and Applications
3.7 Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Juvenile Idiopathic Arthritis Diagnostic Breakdown Data by Type
4.1 Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Type (2021–2026)
4.2 Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Type (2027–2032)
5 Juvenile Idiopathic Arthritis Diagnostic Breakdown Data by Application
5.1 Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size by Application (2021–2026)
5.2 Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
6.2 North America Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)
6.4 North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
7.2 Europe Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)
7.4 Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
8.2 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2021–2026)
8.4 Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
9.2 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)
9.4 Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size (2021–2032)
10.2 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2021–2026)
10.4 Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Juvenile Idiopathic Arthritis Diagnostic Introduction
11.1.4 Roche Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Juvenile Idiopathic Arthritis Diagnostic Introduction
11.2.4 Abbott Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.2.5 Abbott Recent Development
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher Juvenile Idiopathic Arthritis Diagnostic Introduction
11.3.4 Danaher Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.3.5 Danaher Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Introduction
11.4.4 Siemens Healthineers Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.4.5 Siemens Healthineers Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Sysmex
11.6.1 Sysmex Company Details
11.6.2 Sysmex Business Overview
11.6.3 Sysmex Juvenile Idiopathic Arthritis Diagnostic Introduction
11.6.4 Sysmex Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.6.5 Sysmex Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Juvenile Idiopathic Arthritis Diagnostic Introduction
11.7.4 BioMerieux Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.7.5 BioMerieux Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Juvenile Idiopathic Arthritis Diagnostic Introduction
11.8.4 Siemens Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.8.5 Siemens Recent Development
11.9 Philips
11.9.1 Philips Company Details
11.9.2 Philips Business Overview
11.9.3 Philips Juvenile Idiopathic Arthritis Diagnostic Introduction
11.9.4 Philips Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.9.5 Philips Recent Development
11.10 GE
11.10.1 GE Company Details
11.10.2 GE Business Overview
11.10.3 GE Juvenile Idiopathic Arthritis Diagnostic Introduction
11.10.4 GE Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.10.5 GE Recent Development
11.11 Canon Medical
11.11.1 Canon Medical Company Details
11.11.2 Canon Medical Business Overview
11.11.3 Canon Medical Juvenile Idiopathic Arthritis Diagnostic Introduction
11.11.4 Canon Medical Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.11.5 Canon Medical Recent Development
11.12 Hitachi
11.12.1 Hitachi Company Details
11.12.2 Hitachi Business Overview
11.12.3 Hitachi Juvenile Idiopathic Arthritis Diagnostic Introduction
11.12.4 Hitachi Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.12.5 Hitachi Recent Development
11.13 United Imaging
11.13.1 United Imaging Company Details
11.13.2 United Imaging Business Overview
11.13.3 United Imaging Juvenile Idiopathic Arthritis Diagnostic Introduction
11.13.4 United Imaging Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
11.13.5 United Imaging Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Blood Tests
Table 3. Key Players of Imaging Scans
Table 4. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2021–2026
Table 7. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2021–2026)
Table 8. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2027–2032)
Table 10. Juvenile Idiopathic Arthritis Diagnostic Market Trends
Table 11. Juvenile Idiopathic Arthritis Diagnostic Market Drivers
Table 12. Juvenile Idiopathic Arthritis Diagnostic Market Challenges
Table 13. Juvenile Idiopathic Arthritis Diagnostic Market Restraints
Table 14. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Players (US$ Million), 2021–2026
Table 15. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Players (2021–2026)
Table 16. Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Tier (Tier 1, Tier 2, and Tier 3), based on Juvenile Idiopathic Arthritis Diagnostic Revenue, 2025
Table 17. Ranking of Global Top Juvenile Idiopathic Arthritis Diagnostic Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Juvenile Idiopathic Arthritis Diagnostic Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Headquarters and Area Served
Table 20. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Products and Applications
Table 21. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Type (US$ Million), 2021–2026
Table 24. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2021–2026)
Table 25. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2027–2032)
Table 27. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Application (US$ Million), 2021–2026
Table 28. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2021–2026)
Table 29. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2027–2032)
Table 31. North America Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 33. North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Juvenile Idiopathic Arthritis Diagnostic Product
Table 49. Roche Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 50. Roche Recent Development
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Juvenile Idiopathic Arthritis Diagnostic Product
Table 54. Abbott Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 55. Abbott Recent Development
Table 56. Danaher Company Details
Table 57. Danaher Business Overview
Table 58. Danaher Juvenile Idiopathic Arthritis Diagnostic Product
Table 59. Danaher Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 60. Danaher Recent Development
Table 61. Siemens Healthineers Company Details
Table 62. Siemens Healthineers Business Overview
Table 63. Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Product
Table 64. Siemens Healthineers Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 65. Siemens Healthineers Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Product
Table 69. Thermo Fisher Scientific Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Sysmex Company Details
Table 72. Sysmex Business Overview
Table 73. Sysmex Juvenile Idiopathic Arthritis Diagnostic Product
Table 74. Sysmex Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 75. Sysmex Recent Development
Table 76. BioMerieux Company Details
Table 77. BioMerieux Business Overview
Table 78. BioMerieux Juvenile Idiopathic Arthritis Diagnostic Product
Table 79. BioMerieux Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 80. BioMerieux Recent Development
Table 81. Siemens Company Details
Table 82. Siemens Business Overview
Table 83. Siemens Juvenile Idiopathic Arthritis Diagnostic Product
Table 84. Siemens Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 85. Siemens Recent Development
Table 86. Philips Company Details
Table 87. Philips Business Overview
Table 88. Philips Juvenile Idiopathic Arthritis Diagnostic Product
Table 89. Philips Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 90. Philips Recent Development
Table 91. GE Company Details
Table 92. GE Business Overview
Table 93. GE Juvenile Idiopathic Arthritis Diagnostic Product
Table 94. GE Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 95. GE Recent Development
Table 96. Canon Medical Company Details
Table 97. Canon Medical Business Overview
Table 98. Canon Medical Juvenile Idiopathic Arthritis Diagnostic Product
Table 99. Canon Medical Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 100. Canon Medical Recent Development
Table 101. Hitachi Company Details
Table 102. Hitachi Business Overview
Table 103. Hitachi Juvenile Idiopathic Arthritis Diagnostic Product
Table 104. Hitachi Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 105. Hitachi Recent Development
Table 106. United Imaging Company Details
Table 107. United Imaging Business Overview
Table 108. United Imaging Juvenile Idiopathic Arthritis Diagnostic Product
Table 109. United Imaging Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 110. United Imaging Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Juvenile Idiopathic Arthritis Diagnostic Picture
Figure 2. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Type: 2025 vs 2032
Figure 4. Blood Tests Features
Figure 5. Imaging Scans Features
Figure 6. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Application: 2025 vs 2032
Figure 8. Hospitals Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Juvenile Idiopathic Arthritis Diagnostic Report Years Considered
Figure 12. Global Juvenile Idiopathic Arthritis Diagnostic Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region: 2025 vs 2032
Figure 15. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Players in 2025
Figure 16. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Juvenile Idiopathic Arthritis Diagnostic Revenue in 2025
Figure 18. North America Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)
Figure 20. United States Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)
Figure 24. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2021–2032)
Figure 32. China Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)
Figure 40. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)
Figure 44. Israel Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Roche Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 48. Abbott Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 49. Danaher Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 50. Siemens Healthineers Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 52. Sysmex Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 53. BioMerieux Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 54. Siemens Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 55. Philips Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 56. GE Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 57. Canon Medical Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 58. Hitachi Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 59. United Imaging Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Blood Tests
Table 3. Key Players of Imaging Scans
Table 4. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2021–2026
Table 7. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2021–2026)
Table 8. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2027–2032)
Table 10. Juvenile Idiopathic Arthritis Diagnostic Market Trends
Table 11. Juvenile Idiopathic Arthritis Diagnostic Market Drivers
Table 12. Juvenile Idiopathic Arthritis Diagnostic Market Challenges
Table 13. Juvenile Idiopathic Arthritis Diagnostic Market Restraints
Table 14. Global Juvenile Idiopathic Arthritis Diagnostic Revenue by Players (US$ Million), 2021–2026
Table 15. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Players (2021–2026)
Table 16. Global Top Juvenile Idiopathic Arthritis Diagnostic Players by Tier (Tier 1, Tier 2, and Tier 3), based on Juvenile Idiopathic Arthritis Diagnostic Revenue, 2025
Table 17. Ranking of Global Top Juvenile Idiopathic Arthritis Diagnostic Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Juvenile Idiopathic Arthritis Diagnostic Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Headquarters and Area Served
Table 20. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Products and Applications
Table 21. Global Key Players of Juvenile Idiopathic Arthritis Diagnostic, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Type (US$ Million), 2021–2026
Table 24. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2021–2026)
Table 25. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Type (2027–2032)
Table 27. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Application (US$ Million), 2021–2026
Table 28. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2021–2026)
Table 29. Global Juvenile Idiopathic Arthritis Diagnostic Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Juvenile Idiopathic Arthritis Diagnostic Revenue Market Share by Application (2027–2032)
Table 31. North America Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 33. North America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size by Country (US$ Million), 2027–2032
Table 46. Roche Company Details
Table 47. Roche Business Overview
Table 48. Roche Juvenile Idiopathic Arthritis Diagnostic Product
Table 49. Roche Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 50. Roche Recent Development
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Juvenile Idiopathic Arthritis Diagnostic Product
Table 54. Abbott Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 55. Abbott Recent Development
Table 56. Danaher Company Details
Table 57. Danaher Business Overview
Table 58. Danaher Juvenile Idiopathic Arthritis Diagnostic Product
Table 59. Danaher Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 60. Danaher Recent Development
Table 61. Siemens Healthineers Company Details
Table 62. Siemens Healthineers Business Overview
Table 63. Siemens Healthineers Juvenile Idiopathic Arthritis Diagnostic Product
Table 64. Siemens Healthineers Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 65. Siemens Healthineers Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Juvenile Idiopathic Arthritis Diagnostic Product
Table 69. Thermo Fisher Scientific Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Sysmex Company Details
Table 72. Sysmex Business Overview
Table 73. Sysmex Juvenile Idiopathic Arthritis Diagnostic Product
Table 74. Sysmex Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 75. Sysmex Recent Development
Table 76. BioMerieux Company Details
Table 77. BioMerieux Business Overview
Table 78. BioMerieux Juvenile Idiopathic Arthritis Diagnostic Product
Table 79. BioMerieux Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 80. BioMerieux Recent Development
Table 81. Siemens Company Details
Table 82. Siemens Business Overview
Table 83. Siemens Juvenile Idiopathic Arthritis Diagnostic Product
Table 84. Siemens Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 85. Siemens Recent Development
Table 86. Philips Company Details
Table 87. Philips Business Overview
Table 88. Philips Juvenile Idiopathic Arthritis Diagnostic Product
Table 89. Philips Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 90. Philips Recent Development
Table 91. GE Company Details
Table 92. GE Business Overview
Table 93. GE Juvenile Idiopathic Arthritis Diagnostic Product
Table 94. GE Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 95. GE Recent Development
Table 96. Canon Medical Company Details
Table 97. Canon Medical Business Overview
Table 98. Canon Medical Juvenile Idiopathic Arthritis Diagnostic Product
Table 99. Canon Medical Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 100. Canon Medical Recent Development
Table 101. Hitachi Company Details
Table 102. Hitachi Business Overview
Table 103. Hitachi Juvenile Idiopathic Arthritis Diagnostic Product
Table 104. Hitachi Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 105. Hitachi Recent Development
Table 106. United Imaging Company Details
Table 107. United Imaging Business Overview
Table 108. United Imaging Juvenile Idiopathic Arthritis Diagnostic Product
Table 109. United Imaging Revenue in Juvenile Idiopathic Arthritis Diagnostic Business (US$ Million), 2021–2026
Table 110. United Imaging Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Juvenile Idiopathic Arthritis Diagnostic Picture
Figure 2. Global Juvenile Idiopathic Arthritis Diagnostic Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Type: 2025 vs 2032
Figure 4. Blood Tests Features
Figure 5. Imaging Scans Features
Figure 6. Global Juvenile Idiopathic Arthritis Diagnostic Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Application: 2025 vs 2032
Figure 8. Hospitals Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Juvenile Idiopathic Arthritis Diagnostic Report Years Considered
Figure 12. Global Juvenile Idiopathic Arthritis Diagnostic Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Juvenile Idiopathic Arthritis Diagnostic Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Region: 2025 vs 2032
Figure 15. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Players in 2025
Figure 16. Global Juvenile Idiopathic Arthritis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Juvenile Idiopathic Arthritis Diagnostic Revenue in 2025
Figure 18. North America Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)
Figure 20. United States Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)
Figure 24. Germany Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Share by Region (2021–2032)
Figure 32. China Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)
Figure 40. Mexico Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Juvenile Idiopathic Arthritis Diagnostic Market Share by Country (2021–2032)
Figure 44. Israel Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Juvenile Idiopathic Arthritis Diagnostic Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Roche Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 48. Abbott Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 49. Danaher Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 50. Siemens Healthineers Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 52. Sysmex Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 53. BioMerieux Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 54. Siemens Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 55. Philips Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 56. GE Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 57. Canon Medical Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 58. Hitachi Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 59. United Imaging Revenue Growth Rate in Juvenile Idiopathic Arthritis Diagnostic Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232